Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB3 | P13945 | 6/20 | 0.70 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.70 |
| ▸ | LMNA | P02545 | 2/20 | 0.70 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.70 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.70 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.70 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.70 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.70 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.70 |
| ▸ | GALR3 | O60755 | 1/20 | 0.70 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.70 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.70 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.70 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.68 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6373611 | 1.00 | ADRB3 (0.70) | ADRB3ADRB2LMNAHIF1ASLC6A2 | |
| SCHEMBL2495187 | 1.00 | ADRB3 (0.70) | ADRB3ADRB2LMNAHIF1ASLC6A2 | |
| Water SCHEMBL8025132 | 0.99 | ADRB3 (0.69) | ADRB3ADRB2LMNAHIF1ASLC6A2 | |
| Water SCHEMBL8025128 | 0.99 | ADRB3 (0.69) | ADRB3ADRB2LMNAHIF1ASLC6A2 | |
| SCHEMBL7724401 | 0.87 | ADRB3 (0.72) | ADRB3ADRB2LMNAHIF1ASLC6A2 | |
| SCHEMBL7724409 | 0.87 | ADRB3 (0.72) | ADRB3ADRB2LMNAHIF1ASLC6A2 | |
| SCHEMBL7728737 | 0.86 | ADRB2 (0.60) | ADRB3ADRB2LMNAHIF1ASLC6A2 | |
| SCHEMBL7728744 | 0.86 | ADRB2 (0.60) | ADRB3ADRB2LMNAHIF1ASLC6A2 | |
| SCHEMBL2442129 | 0.86 | ADRB2 (0.62) | ADRB3ADRB2LMNAHIF1ASLC6A2 | |
| Hydrochloric Acid SCHEMBL7723671 | 0.85 | ADRB3 (0.61) | ADRB3ADRB2LMNAHIF1ASLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1002791-B1 | AMINOETHYLPHENOXYACETIC ACID DERIVATIVES AND DRUGS FOR PAIN REMISSION AND CALCULI REMOVAL PROMOTION IN URINARY LITHIASIS | KISSEI PHARMACEUTICAL (JP) | 2004-10-20 | — | — | EP | claimed |
| EP-1657235-B1 | Phenethanolamine-derived haptens, immunogens and conjugates comprising them and antibodies recognising said immunogenes and conjugates | RANDOX LAB LTD (GB) | 2011-09-21 | — | — | EP | disclosed |
| EP-1657235-B1 | Phenethanolamine-derived haptens, immunogens and conjugates comprising them and antibodies recognising said immunogenes and conjugates | RANDOX LAB LTD (GB) | 2011-09-21 | — | — | EP | disclosed |
| US-7192722-B2 | Phenethanolamine-derived haptens, immunogens, antibodies and conjugates | RANDOX LABORATORIES (GB) | 2007-03-20 | — | — | US | disclosed |
| US-7192722-B2 | Phenethanolamine-derived haptens, immunogens, antibodies and conjugates | RANDOX LABORATORIES (GB) | 2007-03-20 | — | — | US | disclosed |
| US-20060223132-A1 | uses in competitive immunoassays for the detection of ractopamine, isoxsuprine and ritodrine | RANDOX LABORATORIES LIMITED (GB) | 2006-10-05 | — | — | US | disclosed |
| EP-1657235-A2 | Phenethanolamine-derived haptens, immunogens and conjugates comprising them and antibodies recognising said immunogenes and conjugates | Randox Laboratories Ltd. (GB) | 2006-05-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060223132-A1 | uses in competitive immunoassays for the detection of ractopamine, isoxsuprine and ritodrine | HRH3, HRH4, HRH1 | ADRB3 66/4885ADRB2 14/4885LMNA 4334/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.